Neurogene Inc.
NGNE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $366,849 | $314,778 | $245,867 | $339,579 |
| - Cash | $71,005 | $58,813 | $70,771 | $136,586 |
| + Debt | $10,208 | $10,966 | $13,543 | $12,428 |
| Enterprise Value | $306,052 | $266,931 | $188,639 | $215,421 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$15,347 |
| % Margin | – | – | – | – |
| EBITDA | -$20,176 | -$21,248 | -$21,883 | -$20,714 |
| % Margin | – | – | – | – |
| Net Income | -$20,953 | -$22,016 | -$22,647 | -$19,514 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.99 | -1.05 | -1.08 | -1.31 |
| % Growth | 5.7% | 2.8% | 17.6% | – |
| Operating Cash Flow | -$19,683 | -$19,462 | -$20,774 | -$17,496 |
| Capital Expenditures | -$126 | -$148 | -$780 | -$116 |
| Free Cash Flow | -$19,809 | -$19,610 | -$21,554 | -$17,612 |